**Core Concept**
Filgrastim is a recombinant human granulocyte-colony stimulating factor (G-CSF) used to stimulate the production of white blood cells, specifically neutrophils, in patients with certain types of cancer or conditions that affect the bone marrow.

**Why the Correct Answer is Right**
Filgrastim works by binding to its receptor on the surface of hematopoietic cells, including neutrophils, and stimulating them to proliferate and differentiate into mature cells. This leads to an increase in the production of neutrophils, which helps to prevent infections and reduce the risk of complications in patients with neutropenia. Filgrastim is commonly used in patients undergoing chemotherapy, bone marrow transplantation, or those with conditions such as congenital neutropenia.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because Filgrastim is not used to treat anemia.
* Anemia is typically treated with erythropoiesis-stimulating agents such as erythropoietin.

**Option B:** This option is incorrect because Filgrastim is not used to treat thrombocytopenia.
* Thrombocytopenia is typically treated with thrombopoietin-receptor agonists such as romiplostim.

**Option C:** This option is incorrect because Filgrastim is not used to treat autoimmune disorders.
* Autoimmune disorders are typically treated with immunosuppressive agents such as corticosteroids or biologics.

**Clinical Pearl / High-Yield Fact**
A key clinical consideration when using Filgrastim is to monitor patients for signs of bone pain, splenomegaly, or leukocytosis, as these can be side effects of the treatment.

**Correct Answer: C. Neutropenia.